Predict your next investment

Private Equity

See what CB Insights has to offer

Investments

8

Portfolio Exits

1

About Boyi Xintian Fund

Boyi Xintian Fund focuses on investments in the pharmaceutical industry. It was formed by pharmaceutical companies such as Tasly Holdings Group, Chongqing Chemical & Pharmaceutical Holding, and other institutions.

Boyi Xintian Fund Headquarter Location

Chongqing, Chongqing,

China

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Boyi Xintian Fund Investments

8 Investments

Boyi Xintian Fund has made 8 investments. Their latest investment was in SmartNuclide as part of their Series C on July 7, 2021.

CBI Logo

Boyi Xintian Fund Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

7/7/2021

Series C

SmartNuclide

Yes

5

2/11/2021

Series A

Subscribe to see more

$99M

Subscribe to see more

10

9/26/2019

Series A

Subscribe to see more

$99M

Subscribe to see more

10

8/30/2019

Series A

Subscribe to see more

$99M

Subscribe to see more

10

5/28/2018

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/7/2021

2/11/2021

9/26/2019

8/30/2019

5/28/2018

Round

Series C

Series A

Series A

Series A

Series B

Company

SmartNuclide

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$99M

$99M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

5

10

10

10

10

Boyi Xintian Fund Portfolio Exits

1 Portfolio Exit

Boyi Xintian Fund has 1 portfolio exit. Their latest portfolio exit was HitGen on April 16, 2020.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

4/16/2020

IPO

$991

1

Date

4/16/2020

Exit

IPO

Companies

Valuation

$991

Acquirer

Sources

1

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.